These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 18602955

  • 1. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M, Kálmán J.
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [Abstract] [Full Text] [Related]

  • 2. Muscarinic agonists as preventative therapy for Alzheimer's disease.
    Beach TG.
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1633-6. PubMed ID: 12476965
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of nicotinic acetylcholine receptors in Alzheimer's disease.
    Oddo S, LaFerla FM.
    J Physiol Paris; 2006 Nov; 99(2-3):172-9. PubMed ID: 16448808
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanism of cholinergic dysfunction and cognitive deficits induced by amyloid beta-peptide.
    Tran MH, Yamada K, Nabeshima T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Oct; 21(4):125-32. PubMed ID: 11769570
    [Abstract] [Full Text] [Related]

  • 6. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
    Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, Inestrosa NC.
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity.
    Liu Q, Wu J.
    Acta Pharmacol Sin; 2006 Oct; 27(10):1277-86. PubMed ID: 17007734
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor].
    Hashimoto K, Iyo M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Apr; 22(2):49-53. PubMed ID: 12050852
    [Abstract] [Full Text] [Related]

  • 12. [Neurotransmitters in Alzheimer's disease].
    Manzano-Palomo S, De la Morena-Vicente MA, Barquero MS.
    Rev Neurol; 2002 Apr; 42(6):350-3. PubMed ID: 16575771
    [Abstract] [Full Text] [Related]

  • 13. Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease.
    Verhoeff NP.
    Expert Rev Neurother; 2005 Mar; 5(2):277-84. PubMed ID: 15853497
    [Abstract] [Full Text] [Related]

  • 14. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease.
    Coulson EJ, May LM, Sykes AM, Hamlin AS.
    Neuroscientist; 2009 Aug; 15(4):317-23. PubMed ID: 19458382
    [Abstract] [Full Text] [Related]

  • 15. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
    Wang YJ, Zhou HD, Zhou XF.
    Drug Discov Today; 2006 Oct; 11(19-20):931-8. PubMed ID: 16997144
    [Abstract] [Full Text] [Related]

  • 16. Cholinergic function and Alzheimer's disease.
    Giacobini E.
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S1-5. PubMed ID: 12973744
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of synaptic dysfunction in Alzheimer's disease.
    Masliah E.
    Histol Histopathol; 1995 Apr; 10(2):509-19. PubMed ID: 7599445
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease.
    Nordberg A.
    Alzheimer Dis Assoc Disord; 2006 Apr; 20(2 Suppl 1):S12-8. PubMed ID: 16772751
    [Abstract] [Full Text] [Related]

  • 19. Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
    Lai MK, Tsang SW, Garcia-Alloza M, Minger SL, Nicoll JA, Esiri MM, Wong PT, Chen CP, Ramírez MJ, Francis PT.
    Neurobiol Dis; 2006 Jun; 22(3):555-61. PubMed ID: 16473016
    [Abstract] [Full Text] [Related]

  • 20. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.
    Terry AV, Buccafusco JJ.
    J Pharmacol Exp Ther; 2003 Sep; 306(3):821-7. PubMed ID: 12805474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.